Skip to Content

C221 (Ranolazine Extended-Release 500 mg)

Pill with imprint C221 is Yellow, Rectangle and has been identified as Ranolazine Extended-Release 500 mg. It is supplied by Cipla USA Inc..

Ranolazine is used in the treatment of angina and belongs to the drug class antianginal agents. Risk cannot be ruled out during pregnancy. Ranolazine 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for C221

Ranolazine Extended-Release

Imprint
C221
Strength
500 mg
Color
Yellow
Shape
Rectangle
Availability
Prescription only
Drug Class
Antianginal agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cipla USA Inc.
National Drug Code (NDC)
69097-0221

Get help with Imprint Code FAQs.

Related Images for "C221"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.